Concepedia

Geoffrey Wells

GW

43

Publications

3K

Citations

27

H-Index

1975

Active since

Affiliations

University College London(Current)

University of Nottingham

University of Dundee

University of London

King's College London

Geoffrey Wells is an author at University College London specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1975–2022

43

Publications

43

Antitumor Benzothiazoles. 26. 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a Simple Fluorinated 2-Arylbenzothiazole, Shows Potent and Selective Inhibitory Activity against Lung, Colon, and Breast Cancer Cell Lines

Catriona G. Mortimer, Geoffrey Wells, Jean-Philippe Crochard et al. · Journal of Medicinal Chemistry · 2005 · 469 citations

, , +14

Synthesis and Biological Properties of Benzothiazole, Benzoxazole, and Chromen-4-one Analogues of the Potent Antitumor Agent 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648)

Stefania Aiello, Geoffrey Wells, Erica L. Stone et al. · Journal of Medicinal Chemistry · 2008 · 333 citations · Full text

Molecular basis for the disruption of Keap1–Nrf2 interaction via Hinge & Latch mechanism

Yuta Horie, Takafumi Suzuki, Jin Inoue et al. · Communications Biology · 2021 · 162 citations · Full text

PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy

Daniel A. East, Francesca Fagiani, James Crosby et al. · Chemistry & Biology · 2014 · 147 citations · Full text

Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction

Rowena Hancock, Hélène Bertrand, Tadayuki Tsujita et al. · Free Radical Biology and Medicine · 2011 · 145 citations

, , +4

Rows per page

1–5 of 43